Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ: ZNTL · IEX Real-Time Price · USD

3.700

-0.250 (-6.33%)

At close: Jul 19, 2024, 4:00 PM

3.840

+0.140 (3.78%)

Pre-market: Jul 22, 2024, 8:07 AM EDT

Zentalis Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-218.96	-292.19	-236.81	-158.73	-117.84	-45.66	Upgrade
Depreciation & Amortization	1.35	1.39	1.43	0.54	0.16	0.11	Upgrade
Share-Based Compensation	53.92	54.82	46.84	35.74	23.15	0.62	Upgrade
Other Operating Activities	-46.83	28.16	24.79	-31.65	7.71	5.79	Upgrade
Operating Cash Flow	-210.51	-207.82	-163.75	-154.09	-86.83	-39.14	Upgrade
Capital Expenditures	-0.62	-0.58	-2.55	-6.11	-0.76	-0.35	Upgrade
Acquisitions	0	0	0	-14.32	0	0	Upgrade
Change in Investments	-24.41	-43.88	-111.63	2.31	-284.07	0	Upgrade
Investing Cash Flow	-25.03	-44.46	-114.18	-18.12	-284.83	-0.35	Upgrade
Share Issuance / Repurchase	236.94	237.3	261.04	178.52	327.79	0	Upgrade
Other Financing Activities	-	-	-	-	32.65	81.83	Upgrade
Financing Cash Flow	236.94	237.3	261.04	178.52	360.44	81.83	Upgrade
Net Cash Flow	1.39	-14.98	-16.89	6.31	-11.22	42.34	Upgrade
Free Cash Flow	-211.14	-208.41	-166.3	-160.2	-87.58	-39.5	Upgrade
Free Cash Flow Margin	-520.55%	-	-	-	-	-	Upgrade
Free Cash Flow Per Share	-2.98	-3.19	-3.15	-3.75	-3.12	-7.06	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).